Quarterly Call Option Transactions in Cardiff Oncology, Inc. (CRDF)
This table provides information about the institutional ownership of Cardiff Oncology, Inc. (CRDF) during . The information is specifically focused on institutions that hold call options of Cardiff Oncology, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 18,400 | 62,100 | 80,500 | 5,600 | 15,000 | 20,600 | 59,900 | |
| Q4 2021 | 0 | 10,800 | 10,800 | 58,000 | 16,100 | 74,100 | -63,300 | |
| Q1 2022 | 32,400 | 100 | 32,500 | 13,700 | 10,800 | 24,500 | 8,000 | |
| Q2 2022 | 103,100 | 10,300 | 113,400 | 0 | 12,100 | 12,100 | 101,300 | |
| Q3 2022 | 0 | 55,800 | 55,800 | 129,200 | 0 | 129,200 | -73,400 | |
| Q4 2022 | — | 53,300 | 0 | 53,300 | -53,300 | |||
| Q1 2023 | 1,200 | 0 | 1,200 | — | 1,200 | |||
| Q2 2023 | 6,400 | 0 | 6,400 | — | 6,400 | |||
| Q3 2023 | 10,200 | 176,700 | 186,900 | — | 186,900 | |||
| Q4 2023 | — | 164,100 | 0 | 164,100 | -164,100 | |||
| Q1 2024 | 107,700 | 671,600 | 779,300 | — | 779,300 | |||
| Q2 2024 | 31,000 | 0 | 31,000 | 5,400 | 0 | 5,400 | 25,600 | |
| Q3 2024 | 28,200 | 0 | 28,200 | 38,200 | 0 | 38,200 | -10,000 | |